Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives

被引:159
作者
Cao, RH
Chen, Q
Hou, XR
Chen, HS
Guan, HJ
Ma, Y
Peng, WL
Xu, AL
机构
[1] Sun Yat Sen Zhongshan Univ, Coll Life Sci, Dept Biochem, Guangzhou 510275, Peoples R China
[2] Sun Yat Sen Zhongshan Univ, Coll Life Sci, Ctr Biopharmaceut Res, Guangzhou 510275, Peoples R China
关键词
beta-carboline; synthesis; acute toxicity; antitumor; neurotoxicity;
D O I
10.1016/j.bmc.2004.06.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel 9-substituted beta-carboline derivatives was synthesized from harmine and L-tryptophan, respectively. Cytotoxic activities of these compounds in vitro were investigated. The results showed that most compounds of 9-substituted beta-carboline derivatives had more remarkable cytotoxic activities in vitro than their corresponding parent compounds. Acute toxicities and antitumor effects of the selected beta-carboline derivatives in mice were also examined. The results demonstrated that a short alkyl or benzyl substituent at position-9 increased the antitumor activities significantly and a ethoxycarbonyl or carboxyl substituent at position-3 reduced the acute toxicity and neurotoxicity of these beta-carboline derivatives dramatically. Moreover the compounds both with an alkoxycarbonyl or carboxyl substituent at position-3 and a short alkyl or benzyl substituent at positon-9 exhibited more significant antitumor activities and lower acute toxicities and neurotoxicities than the other compounds. The compound 8c, having an n-butyl and a carboxyl substituent at position-9 and 3, respectively, was found to have the highest antitumor effect and the lowest acute toxicity and neurotoxicity. These data suggested that (1) appropriate substituents at both position-9 and 3 of beta-carboline derivatives might play a crucial role in determining their enhanced antitumor activities and decreased acute toxicities and neurotoxic effects; (2) the beta-carboline derivatives have the potential to be used as antitumor drug leads. (C) 2004 Published by Elsevier Ltd.
引用
收藏
页码:4613 / 4623
页数:11
相关论文
共 31 条
[1]   IDENTIFICATION OF TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID IN FOODSTUFFS, HUMAN URINE AND HUMAN-MILK [J].
ADACHI, J ;
MIZOI, Y ;
NAITO, T ;
OGAWA, Y ;
UETANI, Y ;
NINOMIYA, I .
JOURNAL OF NUTRITION, 1991, 121 (05) :646-652
[2]  
AIRAKSINEN MM, 1981, MED BIOL, V59, P21
[3]   Synthesis and cytotoxic evaluation of the first trans-palladium(II) complex with naturally occurring alkaloid harmine [J].
Al-Allaf, TAK ;
Rashan, LJ .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (10) :817-820
[4]   Ortho-directed metalation of 3-carboxy-β-carbolines:: Use of the SmI2-cleavable 9-N-(N′,N′-dimethylsulfamoyl) blocking group for the preparation of 9-N-deprotected 4-amino derivatives via azide introduction or a palladium-catalyzed cross-coupling reaction [J].
Batch, A ;
Dodd, RH .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (03) :872-877
[5]   OCCURRENCE OF 6-HYDROXY-1-METHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE IN TISSUES AND BODY-FLUIDS OF RAT [J].
BECK, O ;
LUNDMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (09) :1507-1510
[6]   URINARY AND BRAIN BETA-CARBOLINE-3-CARBOXYLATES AS POTENT INHIBITORS OF BRAIN BENZODIAZEPINE RECEPTORS [J].
BRAESTRUP, C ;
NIELSEN, M ;
OLSEN, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04) :2288-2292
[7]   MONOAMINE-OXIDASE INHIBITION IN BRAIN AND LIVER PRODUCED BY BETA-CARBOLINES - STRUCTURE-ACTIVITY-RELATIONSHIPS AND SUBSTRATE-SPECIFICITY [J].
BUCKHOLTZ, NS ;
BOGGAN, WO .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (21) :1991-1996
[8]  
Carbrera GM, 1999, J NAT PRODUCTS, V62, P759
[9]   Synthesis of two new heteroaromatic β-carboline-fused pentacycles.: Observation of a new intercalating agent [J].
Csányi, D ;
Hajós, G ;
Riedl, Z ;
Timári, G ;
Bajor, Z ;
Cochard, F ;
Sapi, J ;
Laronze, JY .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) :1767-1769
[10]   The synthesis of amino-acid functionalized β-carbolines as topoisomerase II inhibitors [J].
Deveau, AM ;
Labroli, MA ;
Dieckhaus, CM ;
Barthen, MT ;
Smith, KS ;
Macdonald, TL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) :1251-1255